Search

everythinglearnresearchcommunity

for

Search:↓

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Drugs that block GSK-3 show promise for treating various diseases.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Drug repurposing shows promise for treating many medical conditions.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Liposomes improve minoxidil delivery to hair follicles, enhancing treatment for hair loss.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Corticosteroids can reduce scarring in acne keloidalis by targeting specific cells.

Drugs like PDEI may help hair disorders like AGA.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Human platelets change minoxidil to minoxidil sulfate, helping blood vessels widen.

Liposomes with minoxidil and PEP penetrate skin slowly but reach deeper layers than foam.

New compounds may help treat heart disease by activating specific potassium channels.

Semifluorinated alkanes are promising for delivering drugs in various medical applications.

Reducing SFRP1 can promote hair growth and may help treat hair loss.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.

The new gel effectively treats psoriasis with minimal side effects.

Substance P helps restore skin thickness and cell renewal when sensory nerves are reduced.

Compound 7p shows strong potential as an anticancer agent.